Skip to content
BiologicalX

Comparison

Clomiphene vs Methylene Blue

Side-by-side of Clomiphene and Methylene Blue. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Clomiphene

  • SERM that blocks estrogen-receptor negative feedback at the hypothalamus, raising LH and FSH
  • FDA approved 1967 for ovulation induction in anovulatory women at 50 to 100 mg cycle days 5 to 9
  • Off-label in men at 12.5 to 25 mg daily raises endogenous testosterone while preserving fertility
  • Enclomiphene (trans-isomer) is preferred for male use; cleaner PK and less estrogenic side effect burden
  • Visual disturbances occur in ~1 to 2% of users; persistent symptoms warrant immediate cessation
  • Letrozole has displaced clomiphene as first-line ovulation induction in PCOS (Legro 2014)

Methylene Blue

  • FDA approved for methemoglobinemia and ifosfamide-induced encephalopathy
  • Mitochondrial electron-transport support at low doses (0.5 to 4 mg/kg) via cytochrome c shuttle
  • Potent MAO-A inhibitor; serotonin syndrome risk with SSRIs, SNRIs, MAOIs, fentanyl, tramadol, St John's wort
  • Causes harmless blue-green urine and sweat coloration; useful adherence marker
  • G6PD deficiency is an absolute contraindication; can trigger massive hemolysis
  • Cognitive-enhancement evidence is preliminary, mostly preclinical and small fMRI trials

Side-by-side

Attribute Clomiphene Methylene Blue
Category pharmaceutical pharmaceutical
Also known as Clomid, clomiphene citrate, Serophene, enclomiphene Methylthioninium chloride, Provayblue, tetramethylthionine chloride
Half-life (hr) 168 5.5
Typical dose (mg) 25 70
Dosing frequency 5-day pulse cycle days 5 to 9 (women); daily or every other day (men, off-label) 1 to 3 times daily for cognitive use; single IV dose for methemoglobinemia
Routes oral oral, intravenous
Onset (hr) 6 1
Peak (hr) 7 1.5
Molecular weight 405.96 319.85
Molecular formula C26H28ClNO C16H18ClN3S
Mechanism Selective estrogen receptor modulator that antagonizes estrogen at the hypothalamus and pituitary, increasing GnRH and gonadotropin output, which drives gonadal steroidogenesis. Mitochondrial electron carrier at low doses (cytochrome c shuttle to complex IV) and methemoglobin reductase substrate at higher doses; potent MAO-A inhibitor across the dose range.
Legal status Prescription only (FDA approved for ovulation induction; off-label in men) Prescription (injectable, FDA approved); supplement form (oral) widely available; not scheduled
WADA status banned allowed
DEA / Rx Rx only (not a controlled substance) Not scheduled in the US
Pregnancy Category X; contraindicated in pregnancy Contraindicated
CAS 911-45-5 61-73-4
PubChem CID 1548953 6099
Wikidata Q416785 Q409021

Safety profile

Clomiphene

Common side effects

  • hot flushes
  • mood changes
  • abdominal discomfort
  • breast tenderness
  • visual disturbances (rare)
  • headache

Contraindications

  • pregnancy
  • active liver disease
  • ovarian cysts (not PCOS-related)
  • uncontrolled thyroid or adrenal disorder
  • abnormal uterine bleeding of undetermined origin
  • hormone-sensitive cancer

Interactions

  • tamoxifen: competing SERM activity; not used together(moderate)
  • ospemifene: competing SERM activity(moderate)
  • anastrozole: additive estrogen reduction; sometimes combined in male protocols(minor)
  • TRT (exogenous testosterone): TRT suppresses HPT axis that clomiphene targets; do not combine(moderate)

Methylene Blue

Common side effects

  • blue-green urine and sweat
  • skin and oral mucosa staining
  • GI upset
  • headache
  • dizziness

Contraindications

  • G6PD deficiency
  • pregnancy
  • concurrent serotonergic medication
  • severe renal impairment
  • infants under 6 months

Interactions

  • SSRIs and SNRIs: serotonin syndrome, potentially fatal(major)
  • MAOIs: additive MAO inhibition, serotonin syndrome risk(major)
  • fentanyl, tramadol, meperidine: serotonin syndrome risk(major)
  • dextromethorphan: serotonin syndrome risk(major)
  • St John's wort: serotonin syndrome risk(major)
  • lithium: additive serotonergic risk(major)

Which Should You Take?

Methylene Blue comes out ahead for most readers on the criteria we weight: 3 catalogued goals, controlled substance, oral dosing, with a Tier-A outcome catalogued. Clomiphene is the right call when one of the conditionals below applies.

  • If your priority is hormonal optimization, pick Clomiphene.
  • If your priority is fertility, pick Clomiphene.
  • If your priority is focus or working memory, pick Methylene Blue.
  • If your priority is mitochondrial function, pick Methylene Blue.

Edge case: Clomiphene is contraindicated in pregnancy; Methylene Blue is the safer pick if that applies.

Default choice: Methylene Blue. Wider use case, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Clomiphene only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Clomiphene and Methylene Blue?

Clomiphene and Methylene Blue differ in category (pharmaceutical vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Clomiphene or Methylene Blue?

Clomiphene half-life is 168 hours; Methylene Blue half-life is 5.5 hours.

Can you stack Clomiphene with Methylene Blue?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper